These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8893044)

  • 1. Use of site-specified tritium labelling to confirm the formation of 17-oxosparteine as a minor urinary metabolite of sparteine in man.
    Ritchie JC; Mitchell SC; Smith RL; Zhang AQ
    Xenobiotica; 1996 Sep; 26(9):977-82. PubMed ID: 8893044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselectivity and stereoselectivity of the metabolism of the chiral quinolizidine alkaloids sparteine and pachycarpine in the rat.
    Ebner T; Meese CO; Eichelbaum M
    Xenobiotica; 1991 Jul; 21(7):847-57. PubMed ID: 1776260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP; Michel C; Hofmann U; Jacqz-Aigrain E; Kroemer HK; Peraldi MN; Eichelbaum M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-Sparteine N-16-oxide, a lupin alkaloid from Lygos raetam var. sarcocarpa.
    Abdel-Halim OB; Fattah HA; Halim AF; Murakoshi I
    Acta Pharm Hung; 1997 Jan; 67(1):9-12. PubMed ID: 9100387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The polymorphism of pachycarpine oxidation].
    Piotrovskiĭ VK; Belolipetskaia VG; Rumiantsev DO; Metelitsa VI
    Eksp Klin Farmakol; 1992; 55(4):56-8. PubMed ID: 1458193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further analysis of sparteine oxidation in a Japanese population and comparison with data observed in different ethnic populations.
    Horai Y; Ishizaki T; Eichelbaum M; Hashimoto K; Chiba K; Dengler HJ
    Xenobiotica; 1988 Sep; 18(9):1077-84. PubMed ID: 3227705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
    Hooper WD; Treston AM; Jacobsen NW; Dickinson RG; Eadie MJ
    Drug Metab Dispos; 1983; 11(6):607-10. PubMed ID: 6140148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nuclear magnetic resonance study of sparteine delta metabolite structure.
    Ebner T; Meese CO; Fischer P; Eichelbaum M
    Drug Metab Dispos; 1991; 19(5):955-9. PubMed ID: 1686242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of dimethylamphetamine in rat and man.
    Inoue T; Suzuki S
    Xenobiotica; 1987 Aug; 17(8):965-71. PubMed ID: 3673111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatographic determination of sparteine and 2- and 5-dehydrosparteine in plasma and urine.
    Schellens JH; van der Wart HH; Hoevers JW; Breimer DD
    J Chromatogr; 1988 Sep; 431(1):203-9. PubMed ID: 3235532
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.
    Allen JG; East PB; Francis RJ; Haigh JL
    Drug Metab Dispos; 1975; 3(5):332-7. PubMed ID: 241613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man.
    De Vries JX; Walter-Sack I; Ittensohn A; Weber E
    Xenobiotica; 1989 Dec; 19(12):1461-70. PubMed ID: 2618093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid determination of sparteine and its metabolites in urine.
    Veningerová M; Prachar V; Lukácsová M; Glasa J; Holomán J
    J Chromatogr; 1993 Dec; 622(2):274-7. PubMed ID: 8150877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatography/mass spectrometry characterization of urinary metabolites of danazol after oral administration in human.
    de Oca Porto RM; Fernández AR; Brito DM; Vidal TC; Diaz AL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):178-83. PubMed ID: 16288903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of sparteine and its 2-dehydro and 5-dehydro metabolites in urine by high-performance liquid chromatography with electrochemical detection.
    Moncrieff J
    J Chromatogr; 1990 Jul; 529(1):194-200. PubMed ID: 2211932
    [No Abstract]   [Full Text] [Related]  

  • 19. New evidence of sparteine metabolites in humans.
    Pospísil J; Patzelová V; Máca B
    Drug Metab Dispos; 1992; 20(2):330-2. PubMed ID: 1352230
    [No Abstract]   [Full Text] [Related]  

  • 20. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.